HAIFA, Israel, April 10, 2025 (GLOBE NEWSWIRE) -- Pluri Inc. (PLUR) (“Pluri” or the “Company”), a biotechnology company leveraging its proprietary platform for cell-based solutions to create a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results